Ruth Bader Ginsburg completes radiation therapy
The radiation therapy was administered to treat a tumor on her pancreas (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 24, 2019 Category: Consumer Health News Source Type: news

Justice Ruth Bader Ginsburg Treated for Pancreatic Cancer
Justice Ruth Bader Ginsburg has just finished treatment for pancreatic cancer, the U.S. Supreme Court announced Friday. (Source: WebMD Health)
Source: WebMD Health - August 24, 2019 Category: Consumer Health News Source Type: news

Ruth Bader Ginsburg completes radiation therapy
Supreme Court Justice Ruth Bader Ginsburg has had another bout with cancer. The court announced that Ginsburg, 86, just completed three weeks of radiation treatment for a cancerous tumor on her pancreas. Ed O'Keefe reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 24, 2019 Category: Consumer Health News Source Type: news

Justice Ruth Bader Ginsburg Treated for Pancreatic Cancer
FRIDAY, Aug. 23, 2019 -- Justice Ruth Bader Ginsburg has just finished treatment for pancreatic cancer, the U.S. Supreme Court announced Friday. After the tumor was first diagnosed in late July, Ginsburg was given a three-week course of focused... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 23, 2019 Category: General Medicine Source Type: news

Ruth Bader Ginsburg has pancreatic cancer and received radiation treatments; too bad Google and YouTube are censoring all the cancer cures that really work
(Natural News) U.S. Supreme Court Justice Ruth Bader Ginsburg has pancreatic cancer. Multiple media sources are now reporting that she recently underwent three weeks of radiation treatment for a “localized malignant tumor” that was found on her tumor July 31st of this year. This is her second cancer treatment this year, according to media reports.... (Source: NaturalNews.com)
Source: NaturalNews.com - August 23, 2019 Category: Consumer Health News Source Type: news

New measure for cancer services in Wales hailed as ‘UK first’
Waiting time measured from when disease is first suspected rather than when referral is received in hospital Related items fromOnMedica GP gatekeepers linked to reduced patient satisfaction Diagnosis targets unethical says GP Eight in ten stillbirths might have been avoided GPs need better tools to diagnose pancreatic cancer ‘Friends& family test ’ should not be mandatory (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 23, 2019 Category: UK Health Source Type: news

Pancreatic cancer disappeared in 70% of mice treated with cannabis compound
A compound that give the gives the cannabis plant its color had 'shocking' tumor-shrinking abilities, the Harvard University scientists reported. It may 'teach' the immune system to recognize cancer cells. (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2019 Category: Consumer Health News Source Type: news

Pancreatic Cancer Screening in High-Risk Individuals Pancreatic Cancer Screening in High-Risk Individuals
The USPSTF has upheld its'do not screen'recommendation for pancreatic cancer in the general population, but experts argue for screening for high-risk individuals.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 19, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Busting Some Popular Myths About EPI Busting Some Popular Myths About EPI
Dr David Johnson on the incorrect assumptions that continue to impair the treatment of this pancreatic condition.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - August 19, 2019 Category: Gastroenterology Tags: Gastroenterology Viewpoint Source Type: news

Increased Survival in Metastatic Pancreatic Cancer
Treatment and survival rates for stage IV pancreatic cancer (ie, metastatic pancreatic cancer or MPC) have gone up during in the past 10 years, according to the results of a VA study published in the Journal of Gastrointestinal Oncology. The advent of new anti-neoplastic agents has boosted survival. (Source: CancerNetwork)
Source: CancerNetwork - August 16, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Clinical Trial Offering Personalized Immunotherapy for Mesothelioma
Patients with mesothelioma are now eligible for a multicancer clinical trial studying the effectiveness of personalized immunotherapy at the University of California, San Diego Medical Center. The phase I clinical trial involves a combination of Keytruda (pembrolizumab), a proven immunotherapy drug, and an individualized vaccine based upon the genetic mutations found in each patient’s cancer. “This is the future of cancer treatment,” Dr. Ezra Cohen, principal investigator and director of the San Diego Center for Precision Immunotherapy, told The Mesothelioma Center at Asbestos.com. “Now, we still ha...
Source: Asbestos and Mesothelioma News - August 14, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

New drug shows encouraging survival in pancreatic cancer
A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. A phase 1 clinical trial looked at AZD1775, an inhibitor designed to block an enzyme called Wee1, which plays a role in DNA damage repair. (Source: World Pharma News)
Source: World Pharma News - August 14, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Does Evidence Support Screening for Pancreatic Cancer?
The  U.S. Preventive Services Task Force released a new review of the benefits and harms of imaging-based screening for pancreatic cancer. (Source: CancerNetwork)
Source: CancerNetwork - August 14, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Medical News Today: Pancreatic cancer cells spread by 'educating' the tumor environment
Why does pancreatic cancer spread? The answer may lie in a previously unknown set of molecules that help cancer cells shape the environment around tumors. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 13, 2019 Category: Consumer Health News Tags: Pancreatic Cancer Source Type: news

Can Immunotherapy Play a Role in Pancreatic Ductal Adenocarcinoma?
A combination of  durvalumab and tremelimumab was tested on patients with metastatic pancreatic ductal adenocarcinoma. (Source: CancerNetwork)
Source: CancerNetwork - August 13, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Obesity 'raises cancer risk by TWICE as much as previously thought', study warns
Scientists at the International Agency for Research on Cancer in Lyon, France, found the risk was underestimated for bowel, kidney, pancreatic, endometrial and ovarian cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - August 9, 2019 Category: Consumer Health News Source Type: news

EUS-RF Ablation for Pancreatic Neuroendocrine Tumors EUS-RF Ablation for Pancreatic Neuroendocrine Tumors
This review examines the safety and feasibility of endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors as a minimally invasive procedure for selected patients.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 9, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Promising Blood Test Could Help to Predict Breast Cancer Recurrence
Doctors have gotten much better at detecting and treating breast cancer early. Drug and chemotherapy regimens to control tumors have gotten so effective, in fact, that in some cases, surgery is no longer necessary. In up to 30% of cases of early-stage breast cancer treated before surgery, doctors can’t find evidence of cancer cells in postoperative biopsies. The problem, however, is that there is currently no reliable way to tell which cancers have been pushed into remission and which ones have not. That’s where an easy identifier, like a blood test, could transform the way early stage breast cancer is treated....
Source: TIME: Health - August 8, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized blood tests Breast Cancer Source Type: news

USPSTF: Don't Routinely Screen Adults for Pancreatic Cancer
Based on current evidence, the U.S. Preventive Services Task Force has issued a final recommendation statement against routinely screening asymptomatic adults for pancreatic cancer. This guidance does not apply to patients who are at high risk for the disease. (Source: AAFP News)
Source: AAFP News - August 7, 2019 Category: Primary Care Source Type: news

Routine Screening for Pancreatic Cancer Not Warranted, Expert Panel Says
Title: Routine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysCategory: Health NewsCreated: 8/6/2019 12:00:00 AMLast Editorial Review: 8/7/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 7, 2019 Category: Cancer & Oncology Source Type: news

Pancreas-Tail Radiation Linked to Increased Diabetes Risk Pancreas-Tail Radiation Linked to Increased Diabetes Risk
Radiation to the tail of the pancreas as part of childhood cancer treatment is associated with an increased risk of subsequent diabetes, according to findings from the Childhood Cancer Survivor Study (CCSS).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 7, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Routine Test for Pancreatic Cancer Not Warranted
The U.S. Preventive Services Task Force (USPSTF) on Tuesday reaffirmed its prior recommendation against routine screening for pancreatic cancer. (Source: WebMD Health)
Source: WebMD Health - August 6, 2019 Category: Consumer Health News Source Type: news

USPSTF Reaffirms Recs Against Screening for Pancreatic Cancer
TUESDAY, Aug. 6, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommends against screening for pancreatic adenocarcinoma as the potential benefits do not outweigh the potential harms. These recommendations form the basis of a final... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 6, 2019 Category: Pharmaceuticals Source Type: news

Routine Screening for Pancreatic Cancer Not Warranted, Expert Panel Says
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 6, 2019 Category: Cancer & Oncology Tags: Oncology, Preventive Medicine, News, Source Type: news

USPSTF again dismisses pancreatic cancer screening
The U.S. Preventive Services Task Force (USPSTF) has reaffirmed its prior decision...Read more on AuntMinnie.comRelated Reading: ACS releases blueprint to advance cancer screening Theranostic approach could aid pancreatic cancer patients Contrast US more accurately types pancreatic lesions MRI helpful but not perfect for evaluating pancreatic cancer Ultrasound screens for pancreatic cancer in high-risk populations (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 6, 2019 Category: Radiology Source Type: news

Routine Screening for Pancreatic Cancer Not Warranted, Expert Panel Says
TUESDAY, Aug. 6, 2019 -- There's nothing to be gained by screening for pancreatic cancer in people with no signs or symptoms of the lethal tumor, according to an influential U.S. panel of experts. Looking over the accumulated data on the subject,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 6, 2019 Category: General Medicine Source Type: news

Immunotherapy Failure in Pancreatic Cancer Reveals Potential Path Forward
Negative trial findings suggest immune checkpoint inhibitors may not be the best type of immunotherapy to treat pancreatic cancer. (Source: CancerNetwork)
Source: CancerNetwork - August 6, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

Pancreatic Cancer Screening in Asymptomatic Adults Still Not Recommended
The United States Preventive Services Task Force issued a statement reaffirming its 2004 recommendation against screening for pancreatic cancer in asymptomatic adults. (Source: CancerNetwork)
Source: CancerNetwork - August 6, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Can researchers study your tongue microbiome to determine if you have early-stage pancreatic cancer?
(Natural News) Bacteria can be found in and on every part of the human body, including the tongue. According to a study published in the Journal of Oral Microbiology, analyzing the state of the tongue’s microbiome can tell health experts if a person is experiencing the early stages of pancreatic cancer. The human microbiome is the population... (Source: NaturalNews.com)
Source: NaturalNews.com - August 6, 2019 Category: Consumer Health News Source Type: news

Hyperinsulinemia linked to pancreatic cancer risk
Lowering insulin levels in a mouse model prone to developing pancreatic cancer reduced the incidence of the disease, according to a Canadian study published inCell Metabolism.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 5, 2019 Category: Endocrinology Source Type: news

High insulin levels may bring on pancreatic cancer
Researchers bred mice that were genetically unable to produce excess insulin with mice susceptible to cancer development. The resulting mice had the same pancreatic cancer mutation found in 90 percent of human patients. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 2, 2019 Category: Consumer Health News Source Type: news

Unique combo camera merges PET, SPECT applications
Japanese researchers are reporting success in their first round of human imaging...Read more on AuntMinnie.comRelated Reading: United Imaging makes SNMMI debut in Anaheim NEMA revises manual for gauging SPECT performance Can mobile phones affect gamma camera performance? ASNC releases new guidelines for SPECT MPI Theranostic approach could aid pancreatic cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 1, 2019 Category: Radiology Source Type: news

An Oncologist With Cancer: Mark Lewis Shares Unique Viewpoint An Oncologist With Cancer: Mark Lewis Shares Unique Viewpoint
As an oncologist with pancreatic cancer, Mark Lewis brings a unique, valuable perspective to cancer care. He hopes you'll agree.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 31, 2019 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Cancer Research UK unveils its new £13million centre
One of the first projects at The Cancer Research UK centre - involving experts at The Institute of Cancer Research and Imperial College London - will look at destroying pancreatic tumours. (Source: the Mail online | Health)
Source: the Mail online | Health - July 29, 2019 Category: Consumer Health News Source Type: news

Unleashing AI ’s potential in clinical trial recruitment
The onerous cost of clinical trials in time, money and effort is well documented. The average clinical trial process lasts between 7.5 and 12 years, studies estimate, with costs ranging from $161M - $2.6B per drug. Just 14% of clinical trials are successful and only one in ten drugs entering Phase 1 ends up being approved by the FDA.   Recruitment is a significant source of the problem. According to Christina Busmalis, director of global life sciences at IBM Watson Health,80% of clinical trials do not finish on time and the reason for this, in 86% of cases, is that they do not meet target recruitment on time. &ld...
Source: EyeForPharma - July 29, 2019 Category: Pharmaceuticals Authors: Katie Osborne Source Type: news

Treatment Status in Pancreatic Neuroendocrine Neoplasms Treatment Status in Pancreatic Neuroendocrine Neoplasms
Which pharmacologic agents are available for patients with pancreatic neuroendocrine tumors who are not candidates for surgery?Chinese Clinical Oncology (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 29, 2019 Category: Surgery Tags: Hematology-Oncology Journal Article Source Type: news

Medtronic Looks to Expand Reach of Artificial Pancreas with New Submission
Medtronic fundamentally changed the diabetes management space when it received FDA approval for the MiniMed 670G hybrid closed-loop system back in 2016. The device – dubbed the artificial pancreas has been highly successful used in more than 180,000 people today. The Dublin-based company wants to reach even more patients and has submitted a request to FDA that could help it accomplish its goal. Last week, the firm announced a PMA submission to the agency requesting for non-adjunctive labeling for the Guardian Sensor 3, as part of the MiniMed 670G system. Guardian Sensor 3 is a continuous glucose monitorin...
Source: MDDI - July 26, 2019 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news

Medical News Today: What causes pain in the right upper quadrant of the ribs?
The right upper quadrant of the abdomen includes the pancreas, right kidney, gallbladder, liver, and intestines. Pain under the ribs in this area can indicate an issue affecting one of these organs. Here, learn about possible causes, their treatments, and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 25, 2019 Category: Consumer Health News Tags: Body Aches Source Type: news

Vitamin D supplements may help stave off diabetes as they improve insulin effectiveness 
The hormone made by the pancreas is essential for metabolizing glucose, but in a growing number of people (diabetics) its effects are futile - and without it, suffering ensues. (Source: the Mail online | Health)
Source: the Mail online | Health - July 25, 2019 Category: Consumer Health News Source Type: news

Higher Fasting Plasma Glucose May Up Pancreatic Cancer Risk
THURSDAY, July 25, 2019 -- The incidence rate of pancreatic cancer increases with rising fasting blood glucose levels, even within the normal range, according to a study published online July 24 in the Journal of Clinical Endocrinology&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 25, 2019 Category: Pharmaceuticals Source Type: news

High blood sugar may increase risk for pancreatic cancer
Pancreatic cancer risk may be directly related to elevated blood sugar levels, according to an analysis of health records for 25 million people in South Korea. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 24, 2019 Category: Consumer Health News Source Type: news

High blood sugar 'raises the risk of pancreatic cancer'
A study of more than 25 million people by the Kangbuk Samsung Hospital in Seoul found the life-threatening tumours are more common in those with hyperglycaemia. (Source: the Mail online | Health)
Source: the Mail online | Health - July 24, 2019 Category: Consumer Health News Source Type: news

Riella Earns National Institutes of Health Grant, Department of Defense Award
Leonardo Riella, MD, PhD, medical director of the Vascularized Composite Tissue Transplantation and Associate Medical Director of the Kidney/Pancreas Transplant Program in the Division of Renal Medicine, was awarded an R01 grant from the National In (Source: BWH News)
Source: BWH News - July 24, 2019 Category: Hospital Management Source Type: news

Hope for treating 'silent killer' cancers?
Ovarian and pancreatic cancers are two of the most lethal because they rarely have early symptoms and often go undetected until it is too late. This new US study seeks to change that. (Source: the Mail online | Health)
Source: the Mail online | Health - July 22, 2019 Category: Consumer Health News Source Type: news

Scientists develop promising drug for treating ovarian, pancreatic cancers
(Houston Methodist) Cancer scientists at Houston Methodist have been looking for more effective late-stage treatments for ovarian and pancreatic cancers and may have found one. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2019 Category: International Medicine & Public Health Source Type: news

Chinese herbal formula wu mei wan reduces insulin resistance, protects pancreas, prevents diabetes
(Natural News) Wu mei wan is a Chinese herbal formulation that has been used traditionally to address digestive disorders. Today, this herbal medicine is clinically prescribed to Chinese patients with diabetes mellitus. Two studies conducted by researchers from Huazhong University of Science and Technology in China focused on wu mei wan and its efficacy in treating diabetes.... (Source: NaturalNews.com)
Source: NaturalNews.com - July 18, 2019 Category: Consumer Health News Source Type: news

Novel Test Accurately Identifies Precancerous Pancreatic Cysts
Cyst classifier test is based on clinical and imaging features, genetic and biochemical markers (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 18, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Surgery, Journal, Source Type: news

Algorithm Could Be'Major Leap Forward' for Pancreatic Cysts Algorithm Could Be'Major Leap Forward' for Pancreatic Cysts
Machine-learning trains algorithm to classify pancreatic cysts into low to high risk, potentially sparing patients'unnecessary complex surgery to remove lesions with no malignant potential.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 18, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Novel Test Accurately Identifies Precancerous Pancreatic Cysts
THURSDAY, July 18, 2019 -- A comprehensive test is more accurate than conventional clinical and imaging criteria for identifying precancerous pancreatic cysts, according to a study published online July 17 in Science Translational Medicine. Simeon... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 18, 2019 Category: Pharmaceuticals Source Type: news

Johnny Clegg dies of pancreatic cancer - what are the signs and symptoms?
JOHNNY CLEGG, the British-born musician and one of South Africa ’s most loved hitmakers has died at the age of 66, after a long battle with pancreatic cancer. What is pancreatic cancer and what are the major symptoms to look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2019 Category: Consumer Health News Source Type: news